gamma-Vinyl GABA
gamma-Vinyl GABA Brand names, gamma-Vinyl GABA Analogs
gamma-Vinyl GABA Brand Names Mixture
- No information avaliable
gamma-Vinyl GABA Chemical_Formula
C6H11NO2
gamma-Vinyl GABA RX_link
No information avaliable
gamma-Vinyl GABA fda sheet
gamma-Vinyl GABA msds (material safety sheet)
gamma-Vinyl GABA Synthesis Reference
No information avaliable
gamma-Vinyl GABA Molecular Weight
129.157 g/mol
gamma-Vinyl GABA Melting Point
No information avaliable
gamma-Vinyl GABA H2O Solubility
55.1 mg/mL
gamma-Vinyl GABA State
Solid
gamma-Vinyl GABA LogP
0.056
gamma-Vinyl GABA Dosage Forms
Powder (500 mg sachets); Tablet (500 mg)
gamma-Vinyl GABA Indication
For use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.
gamma-Vinyl GABA Pharmacology
Vigabatrin, is an anticonvulsant chemically unrelated to other anticonvulsants. Vigabatrin inhibits the catabolism of GABA. It is an analog of GABA, but it is not a receptor agonist.
gamma-Vinyl GABA Absorption
Rapidly absorbed following oral administration. Food may slightly decrease the rate, but not the extent, of absorption.
gamma-Vinyl GABA side effects and Toxicity
No information avaliable
gamma-Vinyl GABA Patient Information
This medicine may reduce your ability to drive or operate machinery safely. Do not drive or operate machinery until you know how this medicine affects you and you are sure it won't affect your performance. Avoid stopping this medicine suddenly. The dose of this medicine should be gradually decreased over a period of two to four weeks. After months to years of taking this medication, damage to vision may occur. Regular eye examinations should be conducted and notify your doctor if any change in vision occurs.
gamma-Vinyl GABA Organisms Affected
Humans and other mammals
